维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Muller JS"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Brocnoarterial ratio on thin section CT:comparison between high altitude and sea level显示文摘	Kim JS Muller NL Park CS	1997	J Comoput Assist Tomogr1997，21，：	1
2	Bronchoarterial ratio on thin section CT:Comparison between high altitude and sea level显示文摘	Kim JS Muller NL Park CS	1997	JCAT1997，21，：	1
3	Solid lipid nanoparticles(SLN) - an alternative colloidal carrier system for controlled drug delivery显示文摘	Muller RH Mehnert W Lucks JS	1995	Eur J Pharm Biopharm1995，41，1：	1
4	Brocnoarterial ratio on thinsection CT: comparison between high altitude and sea level显示文摘	Kim JS Muller NL Park CS?	1997	J Comoput Assist Tomogr1997，21，：	1
5	Solid lipid nanoparticles(SLN)-an alternative colloidal carrier system for controlled drug delivery 显示文摘	Muller RH Mehnert W Lucks JS	1995	Eur J Pharm Biopharm1995，41，：	1
6	The congenital myas- thenic syndrome mutation RAPSN N88K derives from anancient Indo-European founder显示文摘	Muller JS Abicht A Burke G	2004	J Med Genet2004，41，：	1
7	Solid lipid nanoparticles (SLN)- an alternative colloidal carrier system for controlled drug delivery 显示文摘	Mehnert W Lucks JS	1995	Eur J Pharm Biopharm1995，41，：	1
8	Combined 17-hydroxylase and 17,20-desmolase deficiencies:evidence for synthesis of a defective cytochrome P450c17显示文摘	Couch RM Muller J	1989	J Clin Endocrinol Metab1989，68，2：	1
9	solid lipid nanoparticles(SLN)-An alernative colloidal carrier system for controlled drug delivery显示文摘	Muller RH Mehnert W Lucks JS	1995	Eur J Pharm1995，41，1：	1
10	Solid lipid nanoparticles(SLN)-an alternative colloidal carrier system for controlled drug delivery显示文摘	Muller RH Mehnert W Lucks JS	1995	Eur J Pharm Biopharm1995，41，：	1
11	Solid lipid micro- nanoparticles(SLN) - An alternative colloidal carrier system for controlled drug delivery显示文摘	Muller RH Mehnert W Lucks JS	1995	Eur J Pharm Biopharm1995，41，12：	1
12	Solid lipid nanoparticlse( SLN)- An alternative colloidal carrier system for controlled drug delivery显示文摘	W Mehnert JS Lucks	1995	Eur J Pharm Biopharm1995，41，6：	1
13	Cylindrical bronchiectasis : Diag- nosis findings on thin-section CT显示文摘	Kim JS Muller NL Park CS	1997	A JR1997，168，：	1
14	HES-1 inhibits 17beta-estradiol and heregulin-betal-mediated upregulation ofE2F-1 显示文摘	Hartman J Muller P Foster JS		Oncogene0，23，54：	1
15	Phenntypical spectru of DOK7 mutations in conngenital myasthenic syndromes 显示文摘	Muller JS Herczegfalvi A Vilchez JJ	2007	Brain2007，130，6：	1
16	Genetic heterogeneity and pathophysiological mechanisms in congenital myasthenic syndromes显示文摘	Barisic N Chaouch A Muller JS	2011	Eur J Paediatr Neurol2011，15，：	1
17	Solid lipid nanoparticles(SLN)-an alternative colloidal carrier system for controlled drug delivery 显示文摘	Mehnert W Lucks JS	1995	Eur J Pharm Biopharm1995，41，1：	1
18	Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations显示文摘	Guergueltcheva V Muller JS Dusl M	2012	J Neurol2012，259，：	1
19	Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect显示文摘	Senderek J Muller JS Dusl M	2011	Am J Hum Genet2011，88，：	1
20	Head-direction cells recorded from the postsubiculum in freely moving rats: I Description and quantitative analysis显示文摘	Taube JS Muller RU Ranck JB Jr	1990	J Neurosci1990，10，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示